We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
162 hedge funds and large institutions have $2.33B invested in Acadia Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,000% more call options, than puts
Call options by funds: $243M | Put options by funds: $22.1M
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
8% more capital invested
Capital invested by funds: $2.16B → $2.33B (+$168M)
1% more funds holding
Funds holding: 160 → 162 (+2)
12% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 57
Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
50
Reduced
57
Closed
20
Calls
$243M
Puts
$22.1M
Net Calls
+$221M
Net Calls Change
-$54.7M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$41.3M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$30.4M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$15.9M |
| 4 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
+$13.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.4M |
Top Sellers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$52.1M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$25.1M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$16.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$15M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$13.3M |
